Chinese artificial intelligence (AI) start-up DeepSeek, which has remained mute over a release date for its R2 reasoning model, has begun recruiting interns to label medical data to improve the ...

Medicine: Deepseek AI accelerates drug discovery by simulating molecular interactions, predicting treatment outcomes, and identifying potential therapeutic targets.

It takes courage to speak up in China, but not only have murmurs arisen, many are warning of what could go wrong if AI is ...

A research team led by Prof. Li Hai from the Hefei Institutes of Physical Science of the Chinese Academy of Sciences has ...

Benchmark data provided by Quark indicates the healthcare model outperformed DeepSeek’s R1 and V3, and OpenAI’s GPT-4o, in test accuracy.

DeepSeek R1 has significantly improved its depth of reasoning and inference capabilities by leveraging. ... Medicine, Anti-aging Biotechnology, and Nanotechnology. Known for identifying cutting edge ...

The Goldman Sachs Small/Mid Cap Growth Fund (Inst) underperformed its benchmark Index during the first quarter of 2025. Click ...

FROM artificial intelligence to military defence, China has offered a few DeepSeek moments this year, showing that the ...

While some hail DeepSeek as a formidable competitor, others view it as a natural second-mover gaining advantage in an evolving AI landscape. The critical question is whether DeepSeek is the result of ...

Democracies like Taiwan should be less worried about falling behind China’s AI progress, and more worried about the strategic vacuum Chinese technology exposes.

DeepSeek is a generative AI tool - similar to OpenAI's ChatGPT and Google's Gemini ... "Those who have medical needs, in particular, should be seeking help from trained professionals ...

For the quarter, the Voya MidCap Opportunities Fund underperformed the Index on a NAV basis due largely to selection effects.